日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis

凝血酶生成用于预测接受艾美赛珠单抗预防治疗的获得性血友病A患者的突破性出血

Pelzer, Fabius J; Ertekin, Ella I; Oleshko, Olga; Klingberg, Annika; Knöbl, Paul; Pfrepper, Christian; Greil, Richard; Oldenburg, Johannes; Sachs, Ulrich J; Miesbach, Wolfgang; Trautmann-Grill, Karolin; Holstein, Katharina; Eichler, Hermann; Möhnle, Patrick; Hart, Christina; Klamroth, Robert; Tiede, Andreas; Werwitzke, Sonja

Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins

对一种凝血因子VIII/免疫球蛋白重链μ双敲除A型血友病小鼠模型进行表征,以研究其长期暴露于凝血因子VIII蛋白的情况。

Monica, Lara; Oleshko, Olga; Aires, Lina; Wuschko, Silvio; Füner, Jonas; Paul, Helmut; Schauerte, Paul; Jespersen, Ditte Starberg; Belyanskaya, Larisa; Tiede, Andreas; Werwitzke, Sonja

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A

在获得性血友病A患者中,艾美赛珠单抗治疗和延迟免疫抑制可带来持续的生存获益

Schimansky, Inga M; Dobbelstein, Christiane; Klamroth, Robert; Hart, Christina; Sachs, Ulrich J; Greil, Richard; Knöbl, Paul; Oldenburg, Johannes; Miesbach, Wolfgang; Pfrepper, Christian; Trautmann-Grill, Karolin; Möhnle, Patrick; Holstein, Katharina; Eichler, Hermann; Werwitzke, Sonja; Tiede, Andreas

Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study

获得性血友病A中自身抗体的靶点并不局限于因子VIII:来自GTH-AH 01/2010研究的数据

Oleshko, Olga; Werwitzke, Sonja; Klingberg, Annika; Witte, Torsten; Eichler, Hermann; Klamroth, Robert; Holstein, Katharina; Hart, Christina; Pfrepper, Christian; Knöbl, Paul; Greil, Richard; Neumeister, Peter; Reipert, Birgit M; Tiede, Andreas

von Willebrand factor modulates immune complexes and the recall response against factor VIII in a murine hemophilia A model

在小鼠血友病A模型中,血管性血友病因子调节免疫复合物和针对因子VIII的记忆性免疫应答。

Oleshko, Olga; Vollack-Hesse, Nadine; Tiede, Andreas; Hegermann, Jan; Curth, Ute; Werwitzke, Sonja

Long-Term Outcomes after Vaccine-Induced Thrombotic Thrombocytopenia

疫苗诱发血栓性血小板减少症的长期预后

Panagiota, Victoria; Dobbelstein, Christiane; Werwitzke, Sonja; Ganser, Arnold; Cooper, Nina; Sachs, Ulrich J; Tiede, Andreas

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

新冠疫苗接种后出现促血栓形成性免疫性血小板减少症

Tiede, Andreas; Sachs, Ulrich J; Czwalinna, Andreas; Werwitzke, Sonja; Bikker, Rolf; Krauss, Joachim K; Donnerstag, Frank; Weißenborn, Karin; Höglinger, Günter; Maasoumy, Benjamin; Wedemeyer, Heiner; Ganser, Arnold

Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice

重组 VWF 片段可提高血友病 A 小鼠皮下注射 VIII 因子的生物利用度

Nadine Vollack-Hesse, Olga Oleshko, Sonja Werwitzke, Barbara Solecka-Witulska, Christoph Kannicht, Andreas Tiede

Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B

抑制因子 9 RNA 生物合成的非编码变异导致血友病 B 的病理机制及反义寡核苷酸介导的挽救

Simon Krooss, Sonja Werwitzke, Johannes Kopp, Alice Rovai, Dirk Varnholt, Amelie S Wachs, Aurelie Goyenvalle, Annemieke Aarstma-Rus, Michael Ott, Andreas Tiede, Jörg Langemeier, Jens Bohne

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

获得性血友病A (AHA) 缓解和生存的预后因素:GTH-AH 01/2010 研究的结果

Tiede, Andreas; Klamroth, Robert; Scharf, Rüdiger E; Trappe, Ralf U; Holstein, Katharina; Huth-Kühne, Angela; Gottstein, Saskia; Geisen, Ulrich; Schenk, Joachim; Scholz, Ute; Schilling, Kristina; Neumeister, Peter; Miesbach, Wolfgang; Manner, Daniela; Greil, Richard; von Auer, Charis; Krause, Manuela; Leimkühler, Klaus; Kalus, Ulrich; Blumtritt, Jan-Malte; Werwitzke, Sonja; Budde, Eva; Koch, Armin; Knöbl, Paul